Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil for smoking behavior
NCT01250977Phase 2Completed
- Sponsor
- Abramson Cancer Center
- Start
- Jan 2011
- Primary completion
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing Donepezil with Placebo (2 arms). Primary endpoints: Change From Baseline in True Positives on the 3-Back Level of the Letter-N-Back Neurocognitive Task at Day 28 and Change From Baseline in Discriminability on the Penn Continuous Performance Neurocognitive Task at Day 28. Started Jan 2011; status: completed.
02
Drugs
donepezil
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01250977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01250977.